Navigation Links
Liver parasite lacks key genes for fatty acid synthesis: Genome sequencing of Clonorchis sinensis
Date:10/23/2011

The human liver fluke Clonorchis sinensis affects more than 35 million people in South East Asia and 15 million in China. Infection by this parasite causes clonorchiasis. Repeated or chronic infection can lead to serious disease of the liver, gall bladder or bile ducts, including the frequently fatal bile duct cancer - cholangiocarcinoma (CCA). The complete genome sequence the genome of C. sinensis, published in BioMed Central's open access journal Genome Biology, has provided insight into the biochemical pathways available to the fluke and shows that they are lacking enzymes required for fatty acid biosynthesis.

C. sinensis has a complex lifestyle. The eggs float in fresh water until eaten by snail. Once inside the snail they develop and grow into a free swimming stage. These burrow out of the snail and into a fish where the coat themselves in an acid resistant covering. Humans and other mammals are infected by the parasite by eating uncooked fish. Once in the small intestine the flukes migrate to the bile ducts in the liver where they live out their adult lives.

Over 16,250 genes were found within the 516Mb genome (the human genome has about 23,000 genes over 3Gb of DNA). Genes were found corresponding to genes for energy metabolism, both aerobic (used by the juveniles) and anaerobic (used by the adults). While the genes coding for proteins needed for fatty acid metabolism were all present, key enzymes were missing from fatty acid synthesis.

Prof Xinbing Yu, who led the team which performed this work, explained that, "Two other liver flukes S.Japonicum and S. Mansoni are also missing these enzymes. This means that liver flukes evolved to use their host's fatty acids before the species separated." Prof Xinbing concludes, "Genomic information is not only able to help us understand evolution but the sequence of C. sinensis is helping us understand liver fluke biology. This in turn will help find new ways of controlling diseases caused by this parasite or provide new targets for making a vaccine."


'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central
Source:Eurekalert

Related biology news :

1. ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC
2. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
3. Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency
4. RNA molecules, delivery system improve vaccine responses, effectiveness
5. Resveratrol prevents fat accumulation in livers of alcoholic mice
6. FSU researchers discovery leads to $1.5 million grant, potential new treatment of liver fibrosis
7. Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
8. Depression during pregnancy can double risk of preterm delivery
9. Toxic bile damages the liver
10. New type of vaccines deliver stronger and faster immune response
11. Apple or pear shape is not main culprit to heart woes -- its liver fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology: